KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Hims & Hers Health (HIMS) Receivables - Net: 2020-2024

  • Hims & Hers Health's Receivables - Net fell 8.96% to $6.1 million in Q4 2024 from the same period last year, while for Dec 2024 it was $6.1 million, marking a year-over-year decrease of 8.96%. This contributed to the annual value of $6.1 million for FY2024, which is 8.96% down from last year.
  • Per Hims & Hers Health's latest filing, its Receivables - Net stood at $6.1 million for Q4 2024, which was down 8.96% from $6.7 million recorded in Q4 2023.
  • Hims & Hers Health's Receivables - Net's 5-year high stood at $6.7 million during Q4 2023, with a 5-year trough of $1.1 million in Q4 2020.
  • For the 3-year period, Hims & Hers Health's Receivables - Net averaged around $5.6 million, with its median value being $6.1 million (2024).
  • Its Receivables - Net has fluctuated over the past 5 years, first surged by 272.73% in 2021, then declined by 8.96% in 2024.
  • Quarterly analysis of 5 years shows Hims & Hers Health's Receivables - Net stood at $1.1 million in 2020, then skyrocketed by 272.73% to $4.1 million in 2021, then dropped by 4.88% to $3.9 million in 2022, then soared by 71.79% to $6.7 million in 2023, then dropped by 8.96% to $6.1 million in 2024.
  • Its Receivables - Net was $6.1 million in Q4 2024, compared to $6.7 million in Q4 2023 and $3.9 million in Q4 2022.